Target
interferon signaling
6 abstracts
Abstract
Phase I, open-label, dose-escalation trial investigating the safety and efficacy of oncolytic virus BI 1821736 in patients with advanced solid tumors.Org: Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Limited,
Abstract
Longitudinal assessment of cardiac involvement in Erdheim-Chester disease using cardiac magnetic resonance imaging.Org: Hôpital Pitié-Salpêtrière, Service de Médecine Interne 2, Hôpital Pitié Salpêtrière, Assistance Publique Hôpitaux de Paris (AP-HP), Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany,
Abstract
Ex-vivo analysis of programmed cell death on fibrolamellar carcinoma.Org: Rush University Medical School, FibroFighters Foundation, Nagourney Cancer Institute, FibroFighters.org, Rush University Medical Center,
Abstract
Augmented curation of disease diagnoses and medications for patients with hepatocellular carcinoma.Org: nference, nference Labs,
Abstract
Effectiveness and safety of conventional systemic treatments in classical and endemic Kaposi sarcoma: A multicentric retrospective study of 110 patients.Org: Hopital Saint Louis, SBIM hopital saint Louis, Hopital Cochin, Hopital Henri Mondor, Université de Paris,
Abstract
Impact of adjuvant immunotherapy in resected stage II/III/IV melanoma: A single center experience.Org: Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Barcelona, Spain, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, SOLTI Cancer Research Group, Hospital Vall d'Hebron,